Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Short- and long-term outcome of interferon therapy for chronic hepatitis B infection.

World journal of gastroenterology - 7 Oct 2014

Seo Yasushi, Yano Yoshihiko

Abstract excerpt

Hepatitis B virus (HBV) infection is a serious clinical problem worldwide. Conventional interferon (IFN)-α has been approved for the treatment of chronic hepatitis B (CHB). Short-term studies have demonstrated that IFN-based therapy is moderately effective in inducing the loss of hepatitis e antigen (HBeAg) or seroconversion (30%-40%) in HBeAg-positive patients and also produces sustained HBV DNA suppression...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Hepatocellular
Share to Hepatitis B, Chronic
Share to Hepatitis B e Antigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B virus

Share to Interferon-alpha

Share to Liver Cirrhosis

Share to Liver Neoplasms

Share to Viral Load

Source

Open in PubMed Open full text

Identifiers

PMID: 25309065
DOI: 10.3748/wjg.v20.i37.13284
PMCID: PMC4188886

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Short- and long-term outcome of interferon therapy for chronic hepatitis B infection.PMID 25309065Read ↗

Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma.Semantic proximity Read ↗

Long-term efficacy of interferon therapy in patients with chronic hepatitis B virus infection in Japan.Semantic proximity Read ↗

Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.Semantic proximity Read ↗

Long-term follow-up of Japanese patients with chronic hepatitis B treated with interferon-alpha.Semantic proximity Read ↗

Efficacy of short-term interferon therapy for patients infected with hepatitis C virus genotype 2a.Semantic proximity Read ↗

Interferon Therapy of Chronic Hepatitis BSemantic proximity Read ↗

The benefits of interferon treatment in patients without sustained viral response after living donor liver transplantation for hepatitis C.Semantic proximity Read ↗

[Interferon in hepatitis B].Semantic proximity Read ↗

Efficacy of alpha-interferon therapy of chronic hepatitis patients infected with wild type hepatitis B virus and HBEAG-minus mutant.Semantic proximity Read ↗

Long-term effect of interferon therapy in patients with HBeAg positive chronic hepatitis B infection.Semantic proximity Read ↗

Potential capacity of interferon-α to eliminate covalently closed circular DNA (cccDNA) in hepatocytes infected with hepatitis B virusSemantic proximity Read ↗

Efficacy of 6-month interferon therapy in chronic hepatitis B virus infection in Japan.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.